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Background: Next-generation DNA sequencing (NGS) technologies have made huge impacts in many fields
of biological research, but especially in evolutionary biology. One area where NGS has shown potential is for
high-throughput sequencing of complete mtDNA genomes (of humans and other animals). Despite the increasing
use of NGS technologies and a better appreciation of their importance in answering biological questions, there remain
significant obstacles to the successful implementation of NGS-based projects, especially for new users.
Results: Here we present an ‘A to Z’ protocol for obtaining complete human mitochondrial (mtDNA) genomes – from
DNA extraction to consensus sequence. Although designed for use on humans, this protocol could also be used to
sequence small, organellar genomes from other species, and also nuclear loci. This protocol includes DNA extraction,
PCR amplification, fragmentation of PCR products, barcoding of fragments, sequencing using the 454 GS FLX platform,
and a complete bioinformatics pipeline (primer removal, reference-based mapping, output of coverage plots and
SNP calling).
Conclusions: All steps in this protocol are designed to be straightforward to implement, especially for researchers
who are undertaking next-generation sequencing for the first time. The molecular steps are scalable to large numbers
(hundreds) of individuals and all steps post-DNA extraction can be carried out in 96-well plate format. Also, the protocol
has been assembled so that individual ‘modules’ can be swapped out to suit available resources.
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Next-generation DNA sequencing (NGS) technologies have
made huge impacts in many fields of biological research,
but especially in evolutionary biology [1,2]. Concurrent
with the increased use of NGS technologies has been
an improved understanding of the amount and type of
data required to answer certain types of evolutionary
and population genetics questions. For example, where
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stated.seen as increasingly necessary to obtain complete mito-
chondrial genomes. This is especially true in studies of
humans, but for other animal species also [3]. The use of
complete mtDNA genomes can help mitigate the reduced
phylogenetic resolution, homoplasy and ascertainment
bias that is otherwise encountered when using markers for
known single nucleotide polymorphisms (SNPs) or shorter
mtDNA sequences (e.g., control region) [4,5]. For human
populations that are poorly studied, complete mtDNA
genomes are even more important because there are often
few known SNPs and, therefore, the relevant regions of the
mitochondrial phylogenetic tree may be poorly resolved.
In addition to evolutionary applications, complete
mtDNA genomes are also being sequenced to identifytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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advent of NGS has seen the significant expansion of
research in this area [6]. For example, NGS of mtDNA
genomes is being used to clinically diagnose mitochon-
drial diseases in individuals with phenotypic evidence
of mitochondrial oxidative phosphorylation disease [7].
The high sensitivity of NGS means it is also being used to
discover diseases associated with low-level mitochondrial
heteroplasmy that would be undetectable with conven-
tional Sanger sequencing [8].
Despite the increasing use of NGS technologies and
a better appreciation of their importance, there remain
significant obstacles to the successful implementation
of NGS-based projects. These challenges often relate
to assembling the constituent components of a NGS
sequencing protocol into a single workflow to suit a given
study. NGS workflows are often complex, and necessarily
span everything from the generation of suitable starting
template, to various molecular biological steps, to the
generation of the raw sequence data, and finally to
the bioinformatic steps required to convert those data
into a suitable format for downstream phylogenetic or
population genetic analyses. New problems can arise
when scaling up a protocol for use on tens or hundreds
of individuals; protocols need to be robust and remain
time efficient. The bioinformatics steps offer their own
challenges because although many of the individual
components/programs are available (e.g., for primer
removal, mapping/assembly, and SNP calling) it is often
difficult to get the outputs from one component into a
format where they can be used as inputs for other
components. Taken together, the challenges in assembling
a complete NGS protocol represent a major source of
inertia for researchers wanting to undertake NGS studies
for the first time.
Here we present an ‘A to Z’ protocol for obtaining
complete human mitochondrial (mtDNA) genomes –
from DNA extraction to consensus sequence. Although
designed for use on humans, this protocol could also –
with minor modifications – be used to sequence small,
organellar genomes from other species, and also nuclear
loci. An overview of the A to Z method is presented
in Figure 1.
All steps in this protocol are designed to be straight-
forward to implement; although the particular combination
of steps is novel, the reagents and recommended equip-
ment are widely available, and the bioinformatics is easily
performed by non-experts (and can be modified where
necessary). The molecular steps are scalable to large
numbers (hundreds) of individuals and all steps post-DNA
extraction can be carried out in 96-well plate format
(throughput is often a limitation in other protocols).
Also, the protocol has been assembled so that individual
‘modules’ can be swapped out to suit different scientificquestions, facilities, skill sets and budgets. Some of these
alternatives are described in the protocol.
It should be noted that the protocol here is largely
kit-based, with speed, efficiency and throughput the
main priorities. Labs with limited consumables budgets
may wish to investigate non-kit-based alternatives for
some of the more expensive steps. Non-kit-based
methods may, however, decrease reliability and in-
crease labour costs through additional time spent pre-
paring reagents, etc. The decision of whether to use a
kit or a non-kit alternative may also depend on access
to the equipment required in either case, and equip-
ment requirements should be thoroughly investigated
beforehand.
Both consumables and labour costs vary dramatically
across countries, and therefore we have not included
a cost analysis for this protocol because it would not
be broadly applicable. Instead, it is recommended that
researchers create a budget before using this protocol,
where the costs of consumables are balanced against
labour costs, the technical expertise required for different
methods, the number of samples to be processed and the
deadlines for the project.
Although initial sample preparation is still largely carried
out by researchers ‘in-house’, it is increasingly common to
take advantage of the significant cost savings associated
with out-sourcing NGS to an external provider. As such,
researchers using the early steps of the protocol may wish
to investigate out-sourcing the wet lab stages from library
prep onwards. The decision of whether or not to use an
external sequencing provider should also form part of
the project plan.
Methods
Sample collection and DNA extraction
DNA was collected from participants using a buccal
swab. Two swabs were obtained for each participant
(one for immediate use, and one as a back-up). All
samples were obtained with informed consent (Univer-
sity of Auckland Human Participants Ethics Committee
(UAHPEC), Ref. 2008/203). DNA was extracted from
the cheek swabs using a phenol–chloroform method
(see Additional file 1 for the full extraction protocol).
Briefly, DNA samples were digested overnight with
proteinase K and then extracted with phenol, chloro-
form and isoamyl alcohol. DNA was precipitated with
isopropanol, washed with ethanol and eluted in Low
TE (10 mM Tris (pH 8.0), 0.1 mM EDTA (pH 8.0)).
DNA was visualised by running 5 μL aliquots of each
extraction on a 1% (w/v) agarose gel, and successful
DNA extractions were confirmed by the presence of a
band of high molecular weight DNA. DNA samples
were quantified using a PicoGreen quantification assay.
DNA Extraction
(see Additional file 1)
DNA Fragmentation
and Size Selection
(see Additional Files 2
& 3)
Library Preparation
emPCR
Sequencing
.sff
snps_for_haplo
grep.txt
s1.flt.bcf coverage.ps all_consensus
.fasta
s1_cons.fasta s1.fq
Parallel Tagged
Sequencing (see
Meyer et al. [12]) 
Pooling
GS Junior/FLX
Sequencing
Bioinformatics
Pipeline
(see Additional file 4
and Figure 3)
Figure 1 Overview of the A to Z method for high-throughput DNA sequencing of complete human mitochondrial genomes. DNA is
collected using cheek swabs and then extracted using a phenol–chloroform method. Long-range PCR is used to amplify each mitochondrial genome
in two overlapping amplicons. The two amplicons from each genome are then pooled and fragmented using NEBNext dsDNA Fragmentase. Barcoding
of the fragments is then achieved using Parallel Tagged Sequencing (PTS) [12]. Barcoded fragments are then pooled for library preparation,
emulsion PCR (emPCR) and pyrosequencing on the 454 GS FLX platform. Using a number of bioinformatics tools, the resulting sequence data
are de-multiplexed and barcodes and primers are removed. Reference-based mapping (to a circular reference) is carried out, followed by the
output of coverage plots, consensus sequences and SNP calling for each individual.
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mtDNA genomes
Long-range PCR (LR-PCR) is an efficient method for
generating template for sequencing, especially in well-
characterized taxa where LR-PCR primers can be designed
easily (e.g., mammals and birds). In less well studiedlineages where primer design can be problematic, Rolling
Circle Amplification (RCA) has shown to be an effective
alternative to LR-PCR for generating template for NGS
[9]. Even when LR-PCR is possible, some modification of
the protocol may be necessary, such as for species that
have AT-rich mtDNA genomes [10].
Clarke et al. BMC Genomics 2014, 15:68 Page 4 of 12
http://www.biomedcentral.com/1471-2164/15/68The complete human mt genome was amplified from
each individual by generating two overlapping long-range
PCR products of 8511 bp (HumLR_1) and 8735 bp
(HumLR_2) (Table 1). The LR-PCR primers were designed
using Primer3Plus (http://www.bioinformatics.nl/cgi-bin/
primer3plus/primer3plus.cgi), and with no, or very weak,
predicted secondary structures. The primer-binding sites
were positioned to be conserved across the 127 complete
mt genomes in the dataset of Pierson et al. [11].
LR-PCR products were amplified using the Expand Long
Range dNTPack (Roche). Individual reactions contained
1× Expand Long Range Buffer (with 2.5 mM MgCl2),
0.5 mM of each dNTP, 0.3 μM forward primer, 0.3 μM
reverse primer, 3% (v/v) dimethyl sulfoxide (DMSO), 2
U enzyme mix, and 1.5 μL (50–500 ng) genomic DNA
in a total volume of 30 μL. Thermal cycling conditions
were: initial denaturation at 92°C for 2 min; followed
by 10 cycles of denaturation at 92°C for 10 s, annealing
at 55°C for 15 s, and extension at 68°C for 8 min 30 s;
followed by 25 cycles of denaturation at 92°C for 10 s,
annealing at 55°C for 15 s, and extension at 68°C for
8 min 30 s, with the extension time increasing 20 s/cycle
for each subsequent cycle; followed by final extension at
68°C for 7 min; followed by a hold at 10°C.
PCR products were visualised by electrophoresis of a
2 μL aliquot of the PCR on a 1% (w/v) agarose gel.
Successful PCRs were represented by a bright band
(6–15 μg DNA) of the expected size.
Purification and quantification of LR-PCR products
LR-PCR products were purified using the AMPure XP
Kit (Beckman Coulter) and solid-phase reversible immo-
bilization (SPRI) technology. Purifications were carried
out using 1.8 volumes (i.e., 1.8 × the sample volume) of
AMPure XP and exactly as described in Steps 5–8 of
Meyer et al. [12]. Purified DNA was eluted in 25 μL of
10 mM Tris (pH 8.0). The significant advantage of the
SPRI technology is that, using a multi-channel pipette,
an entire 96-well plate can be purified in less than 2
hours. Smaller numbers of samples can be purified using
individual columns (e.g., QIAquick PCR Purification Kit
(Qiagen)) but this is very time-consuming and expensive
with large numbers of samples.
A PicoGreen quantification assay was used to accur-
ately quantify the purified LR-PCR products prior toTable 1 Long-range PCR primers for amplifying the complete
Primer name Sequence (5′–3′) Length (nt) 5′
Ca
HumLR_1F ACGGGAAACAGCAGTGATTAAC 22 80
HumLR_1R CTAGTATGAGGAGCGTTATGGAGTG 25 93
HumLR_2F GTACGCCTAACCGCTAACATTACT 24 89
HumLR_2R GTTTTAAGCTGTGGCTCGTAGTG 23 11fragmentation. To ensure the concentration values of the
samples fell within the linear section of the standard
curve, it was necessary to dilute an aliquot of the purified
samples 20-fold, although the exact dilution required will
depend on the quantification setup.Fragmentation of PCR products using NEBNext
dsDNA fragmentase
For each individual, the two LR-PCR products (HumLR_1
and _2) were pooled in equimolar ratios (493.5 ng and
506.5 ng respectively) to yield a total of 1 μg DNA for
fragmentation. Next, the pooled DNA was fragmented
using the NEBNext dsDNA Fragmentase according to
the manufacturer’s instructions and Additional file 2.
Briefly, dsDNA Fragmentase generates dsDNA breaks
in a time-dependent manner, producing 100–800 bp
fragments, depending on incubation time. Note that the
optimum incubation time must be determined empirically
as described in Additional file 2, although we found it to
be between 10 and 18 minutes.
Alternatively, sonication may be used instead of Frag-
mentase. We have used the Bioruptor® Pico sonication
system, which has provided successful fragmentation
following the manufacturer’s instructions and a 15 s/90
s on/off cycle time for 7–8 cycles.Purification and quantification of fragmentase reactions
Fragmentase reactions were purified using the Polyethylene
Glycol–Bead (PEG–Bead) Solution described in Additional
file 3. Briefly, the beads are isolated from AMPure XP
solution and resuspended in a 10–30% PEG solution,
with the percentage determining the size cut-off below
which fragments are removed. Purifications were carried
out using 1.8 volumes (i.e., 1.8 × the sample volume) of
PEG–Bead Solution and exactly as described in Steps 5–8
of Meyer et al. [12]. Purified DNA was eluted in 20 μL of
10 mM Tris.
A subset of the purified Fragmentase reactions was
run on the Bioanalyzer 2100 using a DNA 7500 chip to
ensure that fragments were within the desired size range
(400–1000 bp). Typical Bioanalyzer fragment profiles are
shown in Figure 2A. A PicoGreen quantification assay
was used to accurately quantify the purified Fragmentase
reaction products prior to barcoding.human mitochondrial genome
–3′ binding position in revised
mbridge Reference Sequence (rCRS)
Expected product size (bp)
7–828 8511
42–9318
98–9021 8735
63–1141
Figure 2 Example fragmentation profiles and coverage plots. Example fragmentation profiles and coverage plots are shown for two
mitochondrial genomes (examples 62 and 80). A. These Bioanalyzer profiles (from a DNA 7500 chip) show pooled long-range PCR products after
digestion with NEBNext dsDNA Fragmentase (10 min at 37°C). The x-axis shows the inferred size of the DNA fragments based on the two internal
markers of known size (the peaks at 50 and 10,380 bp). The y-axis shows the amount of DNA present based on fluorescence units. Both example
digestion profiles show fragments between distributed between ~300 bp and ~5 kb in length, with the distribution skewed towards smaller fragments.
These profiles show fragments in the ideal size range for 454 sequencing. The difference in yields between the two samples is probably due to different
recovery efficiencies in the preceding AMPure XP purification step. Screen captures are taken from the 2100 Expert software (Agilent). B. These
coverage plots for two mitochondrial genomes were generated using the software described in this paper. The x-axis shows the nucleotide
positions based on the revised Cambridge Reference Sequence (rCRS). The y-axis shows coverage depth. The horizontal dashed line indicates
mean coverage for that genome. On the left of each heading line is the individual name (e.g. 62.sff or 80.sff); the following number (here,
16569) is the number of positions that were covered by at least 1 read, and the final number (here, also 16569) is the length of the reference
sequence. Note the large peak from 8,000–9,000 bp, which is discussed in the main text. The blue lines represent the corresponding long-range PCR
products and the associated numbers the positions of the ends of those products (see Table 1). The data used to generated these coverage plots is
available in Additional file 6.
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Barcoding and pooling was carried out exactly as described
in Meyer et al. [12], except that the AMPure XP Kit was
used in place of the AMPure Kit.
Sample library construction and sequencing
Sequencing using GS FLX or GS Junior (454 Life Sciences/
Roche, Germany) offers a complete system for preparing
sequencing libraries and generating sequence data. In con-
cert with the instrument, kits were used for constructing
libraries, carrying out emPCR and sequencing the samples.
Most of the components required to undertake these
processes are supplied in these kits, the exceptions being
a system to accurately quantify DNA and reagents
for performing essential quality control on sequencing
libraries. Below we briefly summarise the GS Junior
sequencing process.
Fragmented and barcode-tagged samples must be accur-
ately quantified before commencing library construction.
We recommend using a fluorometric method, for example,
with PicoGreen or the Qubit system (Cat Number Q32866,Life Technologies, USA). Fragmented, tagged samples from
different individuals are mixed in equal amounts to form a
single pool of DNA molecules. This pooled sample is used
to construct the sequencing library. Adding equal amounts
of DNA from each individual ensures equal representation
of these sequences in the final data output. In the example
described here (whole human mt genomes) the samples are
of equal length. If samples of different length are pooled
for library construction then the mass of DNA used for
each sample should be adjusted accordingly to ensure
coverage levels are the same across all samples (see
‘Fragmentation of PCR products using NEBNext dsDNA
fragmentase’ above). We have successfully constructed
libraries from pooled DNA samples ranging from 80 ng to
750 ng in total.
A single Rapid DNA library was constructed from each
pooled sample using the FLX Titanium Rapid Library Kit
(454 Life Sciences/Roche). Library construction results in
the ligation of specific adaptors to the ends of the DNA
molecules. Following library construction, DNA fragments
less than 500 bp in length, including unligated adaptors,
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(Beckman Coulter). This was achieved by first isolating
the DNA-bead mixture on a SPRIPlate and then discard-
ing the derived buffer as per the manufacturer’s protocol.
The AMPure XP beads were then washed in Size Solution
(supplied with the Rapid Library Kit, 454 Life Sciences/
Roche, Germany) to remove short DNA fragments and
any buffer components from previous reactions. Two
washes using 70% (v/v) ethanol were then carried out
according to the AMPure XP protocol. The bead pellet
was air-dried completely and the size-selected sequencing
library eluted by resuspending the pellet in 53 μL of TE
buffer (10 mM Tris (pH 8.0), 1 mM EDTA (ph 8.0)). The
sequencing library was transferred to a clean tube by
drawing down the beads with the magnet prior to transfer.
Library quality was determined in two ways. First, one
of the sequencing adaptors is supplied pre-labelled with
fluoroscein isothiocyanate (FITC), allowing a fluorescent
plate reader to be used to determine the concentration of
the library in molecules/μL (based on a standard curve).
Standards are supplied with the GS FLX Titanium Rapid
Library Kit (454 Life Sciences/Roche). In our experience,
these libraries yielded between 4.19 × 108 and 5.5 × 108
molecules/μL. Second, the size distribution of the sequen-
cing library is determined from a 1 μL aliquot run on
a High Sensitivity DNA Chip (Agilent Technologies)
on the Bioanalyzer instrument (Agilent Technologies).
Sequencing library DNA fragment size distribution should
be between 350 bp and 2000 bp with a peak distribution
around 700 bp. Libraries with fragment sizes significantly
outside of this range should not be used; this indicates that
Fragmentase reaction conditions should be reoptimised
for DNA preparation.
Preparation of the library for sequencing starts with
emulsion PCR (emPCR) [13], which was carried out using
the GS Junior Titanium emPCR Kit (Lib-L) (454 Life
Sciences/Roche). This process begins with binding a single
DNA molecule from the library to a single Sequence
Capture Bead. The amount of DNA added is critically
important: if too much DNA is added, the beads will bind
multiple DNA molecules resulting in mixed sequence
on each bead and as a result will be unreadable; if not
enough DNA is added, the emPCR will not deliver enough
Sequence Capture Beads for efficient sequencing. For this
project, a ratio of two DNA molecules per bead was used.
The volume of library to add to an aliquot of Sequence
Capture Beads is calculated using the equation (1):
μL of library ¼ molecules per bead 10 million beads
library concentration molecules=μLð Þ
ð1Þ
The steps from emulsion formation to biotin–strepta-
vidin-enrichment were carried out according to themanufacturer’s protocols. Following the enrichment process,
approximately 500,000 Sequence Capture Beads should
remain. Fewer than 500,000 Sequence Capture Beads will
be insufficient for a sequencing run. More than 1.5 million
beads remaining after enrichment indicates that there are
too many beads coated with multiple sequences. These
beads should not be used, as the sequences they hold
cannot be resolved and they will be discarded from the
final data set.
Sequencing was performed using the GS Junior and a
PTP Kit and Sequencing Kit (454 Life Sciences/Roche,
Germany). This method of pyrophosphate-based sequen-
cing is described elsewhere [14,15]. Each run took 10
hours to complete. Control beads seeded onto the
PicoTiterPlate (PTP) at the time of loading indepen-
dently indicated both the chemical and instrument
performance of each sequencing run. The output from
the sequencing run is a computer file (.sff ), containing
quality scores and raw data for each sequence generated
from the run. Only those sequences that pass five quality
filters are present in the final data set. This ensures only
high quality sequence reads progress into the analysis
phase of the project. The final output from the GS Junior
typically yielded between 60,000 and 100,000 quality
sequence reads with an average length of between 350
and 450 bp.Computational raw data processing
In the next step the raw sequencing data are processed for
use in downstream analysis (see Figure 3 for an overview).
Here we present an easy-to-use bash-script-based pipeline
that allows the user to automatically process sequencing
files for single or multiple individuals. The presented
pipeline runs on all UNIX-based operating systems. The
step-by-step protocol is provided in Additional file 4 and
the associated scripts in Additional file 5. Additional file 6
contains two example .sff files that can be used to perform
test runs of the scripts. The presented pipeline consists
of freely available standard tools for read mapping
and post-processing, such as BWA [16], SAMtools [17]
and our own scripts, which complement these tools.
All incorporated scripts run either on Python or Perl,
which should be pre-installed on UNIX operating systems.
It can be used to map and process sequencing reads
from different data sources, such as evolutionary genetics,
medical research or even short, damaged ancient DNA
reads (see [18]).
The presented pipeline first sorts individual reads ac-
cording to their barcodes (for multiplexed libraries), then
removes PCR priming sites, performs reference-based
mapping and finally genotype and variant calling. Different
data quality and quantity statistics are included. These
steps are discussed in more detail below.
Figure 3 Steps in the bioinformatics pipeline. The pipeline automatically converts a single .sff input file from a 454 run containing the raw
sequencing data for one or more individuals into a variety of useful output files, notably including per-individual consensus sequence and
coverage plot files. To simplify usage it begins by detecting whether the necessary C programs have been installed, and automatically compiling
bundled versions if not, before proceeding to the bioinformatics steps.
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and reference-based read mapping
In the first data processing step the .sff file is converted
into a fastq file using sff_extract_0_2_13 (http://bioinf.
comav.upv.es/_downloads/sff_extract_0_2_13). The fastq
format is similar to the commonly used fasta format,
but also stores data quality scores in addition to the
sequence information. The reads are then separated
into per-individual fastq files according to their barcode
using nuntag.pl (Additional files 4 and 5). Nuntag isbased on untag (https://bioinf.eva.mpg.de/pts/), but is
coded in Perl and should thus be much easier to run
than untag, which requires a Haskell compiler and vari-
ous additional libraries to be installed. The source code
for untag is included in Additional file 5 and, once it
has been correctly installed, switching the pipeline to
use it is straightforward.
In the next step, priming sites have to be removed
from the reads because the primer sequence can vary
from the priming site and thus might lead to calling false
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tagcleaner.sourceforge.net/) was used to remove the
long-range priming sites. This software tool looks for
the specific sequences within a specified distance to the
5′ and the 3′ end of the reads. To account for mismatches
and partial primer sites present, the last five nucleotides of
the respective primers were used. The trim_within regions
was specified as 26 for HumLR_1F and HumLR_1R and 25
for HumLR_2F and HumLR_2R, respectively. Alternatively,
the freely available software tool AdapterRemoval [20] can
be used.
In the next step the cleaned reads are aligned using
reference-based mapping. To do so, the pipeline applies
the Burrows–Wheeler Alignment Tool (BWA) with the
bwasw algorithm, which uses heuristic Smith–Waterman-
like alignment to find high-scoring local hits [16]. This ap-
proach is very powerful when applied to long read data
with a high error rate, but can be slower and less accurate
for short low-error mappings [21]. The revised Cambridge
Reference Sequence (rCRS [22]) was used as a reference for
the mapping. Alternatively, other sequences can be used.
For comparing called SNPs across datasets, the same ref-
erence is required for each. In some cases, the rCRS
might differ substantially from the consensus sequence
of the processed reads. In this case a second mapping
against a reference for the inferred haplotype might
lead to more reads being mapped.
Downstream variant and haplotype calling
The resulting sam file is then processed with the soft-
ware SAMtools [17] to call the consensus sequence
and variants such as SNPs. It should be noted that
SAMtools 0.1.18 treats N’s in the reference as A’s when
calling the consensus. Furthermore, wherever a region
of the reference is covered by a single or multiple gaps
in the reads, the program will call the nucleotide(s) of
the reference instead of the gap. Thus, it is recommended
that suspicious SNPs or regions in the original mapping
are checked.
In the following step, the filtered SNPs output from
bcftools (part of the SAMtools software package) are
transformed into an input file for the haplogroup-assign-
ing tool HaploGrep (http://haplogrep.uibk.ac.at/) using a
Perl script (see Additional file 4). The haplotypes can then
be called online (or locally) using HaploGrep.
It should be noted that the current setup does not allow
for calling of indels. Indels are insertions or deletions of
point mutations. In recent years indels in mitochondrial
DNA and mitochondrial DNA analysis in general have
gained wide interest in genetic medicine [23-25]. However,
data produced on the 454 platform shows an increased
rate of false-positive SNPs [26-28], due to problems in call-
ing the correct number of nucleotides in polynucleotide
stretches because of signal-to-noise threshold issues.This limitation might be overcome by deeper sequencing
(higher coverage of the position in question). However,
studies have shown that a higher coverage is not sufficient
to overcome this effect if homopolymeric nucleotide
stretches are longer than 10 nucleotides [26,29]. Studies in
which indels are particularly important, such as on human
diseases [24,25], might need to adapt the approach by
deeper sequencing and allowing SAMtools to call indels
(see online supplementary bioinformatics protocol) or
by avoiding using 454 altogether. It is recommended
that indels are called using technologies with low indel
error rates, such as Illumina.
Heteroplasmy (the presence of more than one mito-
chondrial haplotype per cell) is a common phenomenon
in human mitochondrial DNA. Thus, by default the pipe-
line includes ambiguity codes in the consensus sequence.
However, it should be noted that the downstream haplo-
type assignment using HaploGrep does not support
heteroplasmic sites. Therefore, the major nucleotide has
to be determined by eye prior to using Haplogrep. In
cases of heteroplasmic length polymorphisms a de novo
approach might be more appropriate than reference-based
mapping (see below).
Read quality
The data quality of the mapped reads can be checked
using the freely available software tool FastQC (http://
www.bioinformatics.babraham.ac.uk/projects/fastqc/).
FastQC can be used to infer sequence quality scores, GC
content, read lengths distribution and to identify over-
represented sequences. Base-calling algorithms, such as
Pyrobayes [27] for 454 data, produce per-base quality
scores by analysis of incorporation signals, so-called Phred
scores [30,31]. A Phred score of 20, for example, means
that there is a 1 in 100 chance that the read is incorrectly
mapped [31]. The distribution of Phred scores can easily be
assessed using FastQC. The software is further able to
assess quality values such as read length, sequence GC con-
tent, etc. If the read quality is low, reads can be trimmed
e.g. with the freely available software tool trimmomatic [32].
Coverage plots
Coverage plots showing the number of reads overlapping
each position in the reference genome are useful for
quickly assessing mapping quality (see Figure 2B). The
presented pipeline (Additional file 5 and online sup-
plementary bioinformatics protocol: Additional file 4)
automatically produces a coverage plot for each sample,
which shows coverage level versus reference position as
a greyscale bar graph and the average coverage level as
a dashed line. Plots are broken across lines and pages
as necessary; the default scale factor fits up to 20,000
nucleotides per row and 5 rows per page, which is con-
venient for examining multiple mitochondrial genomes,
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plots are in high-resolution (vector) PostScript format
and can be viewed or printed using the freely available
GhostView program (http://pages.cs.wisc.edu/~ghost/).
A healthy coverage plot shows near-average coverage
across the genome.
All coverage plots we have generated show a peak of
high coverage between 8,000–9,000 bp, which roughly
corresponds to the location of atp8. At the time of writing,
we do not have an explanation for the high number of
reads at this location, but we have ruled out low GC
content (which would cause the dsDNA Fragmentase
to cut more frequently) and it does not appear to be
associated with the end of the long-range fragments, as
no equivalent peak appears near the overlap of HumLR_1
and _2 between positions 807 and 1163. We have also
ruled out any artefacts associated with the bioinformatics
pipeline. The consistent appearance of this peak across
all individuals suggest that it is a product of the nucleo-
tide order in this region (that, for example, may affect
secondary folding and ultimately the number of reads
derived). This high coverage region has no effects on
the consensus sequence obtained.
Important considerations for alignment and assembly
A critical decision is the choice of the appropriate strategy
for alignment and assembly of the sequencing reads. In
general, two approaches can be used to obtain a consensus
sequence or an assembly to call variants: “reference-based
mapping” and “de novo assembly”. If a high-quality refer-
ence sequence is available, as in the case of the human
mitochondrial genome, the sequencing reads can be
mapped against this reference. Reference-based mapping
has some advantages over de novo assembly. Since the
reads are mapped against a reference, reads can be
assembled even if regions in between are poorly or not
at all covered (even without paired-end sequencing librar-
ies). This allows consensus sequences to be generated even
in the presence of missing data. Furthermore, contamin-
ation or sequencing artefacts are usually filtered because
they are unlikely to align to the reference.
Reference-based mapping is commonly used in human
genetic studies that are based upon mitochondrial genomes.
A multitude of freely available software tools for reference-
based mapping are available, including the commonly
used software tools BWA [16] and Bowtie 2 [33]. Available
mitochondrial genome sequences such as the revised
Cambridge Reference Sequence (rCRS) can be used for
the mapping. However, due to the mapping algorithms,
problems can occur in cases such as duplication or dele-
tion of genomic regions. For example, a commonly found
motif in mitochondrial genomes obtained from the Pacific
region is the deletion of a 9 bp (CCCCCTCTA) repetitive
sequence, located between the cytochrome oxidase II(COII) and lysine tRNA (tRNALys) genes. This motif is
commonly present in two copies in Europeans and only
one in the Pacific or Asia [34]. Reference-based mapping
of reads from an individual having only one copy against a
reference containing two copies (such as the rCRS) can
lead to false consensus calling. This phenomenon is due to
the possibility of aligning this motif either to the first or
the second copy in the reference. If different reads are
aligned to different copies, the consensus will call both
copies (see Figure S1 in Additional file 4). This problem
can be overcome either by applying realignment tools
(such as GATK [35]) or de novo assembly. Unfortunately
GATK cannot handle 454 data and was thus not included
in the pipeline. For known deletion or insertion of repeats,
the excessive copy in the reference can be substituted
by “-”, which allows for mapping of the same number
of or fewer copies.
De novo assembly is a powerful approach to align
reads if no high-quality reference sequence or sequence
of a closely related taxon is present. Different free software
tools are available to perform de novo assembly, such as
Velvet [36], MIRA 3 [37] or Newbler (454 software; http://
my454.com/products/analysis-software/index.asp). For a
detailed review on available methods see [38,39]. De novo
assembly is based upon the redundancy of short-read
sequencing and the resulting possibility to find overlap-
ping sequencing reads. This approach strongly benefits
from the availability of longer reads (such as from 454
data) or the sheer number of data reads provided by next-
generation sequencing platforms (such as the Illumina
HiSeq, etc.). The advantages of de novo assembly are that
it is independent of any reference sequence and that it
can be used to detect variants on a population level
(see discussion of repetitive sequence mapping above).
Disadvantages include substantially higher computational
requirements and problems resolving contigs (sequence
fragments inferred from clusters of overlapping reads) into
the correct linear order. Although not implemented in
the presented protocol, software tools such as MIRA 3
[37] (http://sourceforge.net/projects/mira-assembler/) or
the standard 454 de novo assembler Newbler 2.5 (http://
my454.com/products/analysis-software/index.asp) can also
be easily implemented in the pipeline if desired.
Results and discussion
DNA extraction
DNA extractions typically yielded 1–50 μg of high mo-
lecular weight total genomic DNA (that probably also
includes a large proportion of microbial DNA). This
DNA was suitable for routinely amplifying long-range
PCR products (~9 kb). In addition, DNA extracted
using this method was found to be stable at 4°C for at
least 2 months, avoiding the need to repeatedly freeze–
thaw the DNA samples.
Clarke et al. BMC Genomics 2014, 15:68 Page 10 of 12
http://www.biomedcentral.com/1471-2164/15/68Long-range PCR amplification of complete
mtDNA genomes
The long-range primers described in Table 1 have been
used to amplify mt genomes from phylogenetically diverse
individuals (including from haplogroups B, L3*, P, Q, H,
W and T), but it is possible that mutations in the primer-
binding sites for some haplogroups may interfere with
amplification. In these cases, it might be necessary to
redesign the primers for different primer-binding sites,
or to include degenerate bases.
The LR-PCR proved to be highly reliable, with > 95%
of individuals yielding both LR-PCR products on the
first amplification attempt. When the PCR failed, it was
usually for both products of an individual, suggesting a
problem with the DNA, rather than with the PCR itself.
In these cases, if a second PCR attempt also failed then
that individual was re-extracted using the back-up buccal
swab.
The concentration of the undiluted purified LR-PCR
products was typically 200–500 ng/μL.
Fragmentation of PCR Products
Although it is necessary to optimise the dsDNA Frag-
mentase reactions for a given template, this proved to be
an efficient method for fragmenting the long-range PCR
products of a large number of individuals, and produced
consistent results. Although mechanical shearing or
sonication methods (e.g., Covaris and Bioruptor) may
be suitable for small numbers of samples, enzymatic
fragmentation allows higher throughput.
Bioinformatics
The presented pipeline is an easy-to-use Unix shell script
that runs a series of programs (such as TaqCleaner, BWA,
SAMtools) to transform a set of raw-read input files
into a variety of useful output files. In addition to applying
existing freely available software tools, new scripts have
also been developed, e.g. to produce coverage plots, which
show the number of reads overlapping each position in
the reference genome for easy quality assessment, and to
convert SAMtools output files into HaploGrep input files
for convenient haplotype calling. The pipeline has been
set up to work for reads from the 454 sequencing plat-
form (Roche), but it can easily be adjusted to be used
for different platforms such as Illumina Miseq, Hiseq
or IonTorrent (Life Technologies). Due to its modular
organization, it is straightforward to change different parts
of the data processing. Recently, Wilm et al. [40] presented
LoFreq, a freely available variant calling tool (http://
sourceforge.net/projects/lofreq/), that has similar precision
to SAMtools [17] but shows a higher sensitivity in calling
rare variants. Alternative tools, such as LoFreq, can easily
be incorporated into the processing. Our pipeline can
process reads for hundreds of sequences in a very shortamount of time (depending on the number of reads this
is typically only a few minutes on a desktop computer
for mtDNA data). The performance is strongly dependent
on the different tools used in the processing. For detailed
discussions on the performance for different steps such
as variant calling please see the publications for the
respective tools.
Conclusions
Here we present a protocol for sequencing complete
human mitochondrial genomes. This protocol could, how-
ever, be used to sequence mitochondrial genomes from
other species, and also nuclear loci of a similar length.
Our aim is for this protocol to help researchers who are
new to next-generation sequencing make full use of
this technology. The benefits of this protocol include
that it is straightforward to implement, and that the
molecular steps are scalable to large numbers of individuals.
The bioinformatics modules are designed to be reasonably
easy to use for researchers new to command line-based
inputs. Conscious of the different questions, facilities,
skill sets and budgets available across research groups,
we have assembled the protocol so that individual
‘modules’ can be changed to suit a particular project.
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